DTC ads
This article was originally published in The Tan Sheet
Executive Summary
FDA issues final guidance on direct-to-consumer advertising of prescription drugs. The guide does not differ substantially from the draft issued Aug. 8, 1997 (1"The Tan Sheet" Aug. 11, 1997, p. 1)
You may also be interested in...
FDA Rx broadcast guidance seeks more non-promotional, consumer-friendly ads.
FDA Rx BROADCAST GUIDE COULD PRODUCE GREATER COMPETITION FOR OTCs because the agency will allow companies running direct-to-consumer TV and radio ads to include instructions about how consumers can easily obtain more detailed product use information in a non-promotional, more consumer-friendly manner, as well as information about major risks.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands